Global Clinical Diagnostics Market: Industry Analysis and Forecast (2019-2027) by Product, Application, End-Use, and Region

Global Clinical Diagnostics Market size was valued at US$ 58,001.97 Mn in 2019 and the total revenue is expected to grow at 6.2 % through 2019 to 2027, reaching nearly US$ 93,851 Mn in the forecast period.

Global Clinical Diagnostics Market Overview:

The Process of identifying a disease, condition, or injury based on the signs and symptoms a patient is having and the patient’s health history and physical examinations. These tests are performed to avoid major health illnesses and to offer early detection of chronic diseases.

Global Clinical Diagnostics Market Dynamics:

The growth of the clinical diagnostic market is greatly driven by the various kinds of chronic diseases and infectious diseases. As the rate of the disease is rising simultaneously clinical diagnosis is rising due to rapid innovation of technologies and diagnosis offered by the development in the healthcare sector. COVID-19 pandemic has fueled the growth of the clinical diagnostics market owing to a large no. of testing carried out all over the world to identify the infected person and to stop further spread of SARS-CoV-2. Various testing labs entered the market and contributed a huge amount to further growth. The demand for clinical diagnostics has been increased by 26-51% as per the survey carried out by Brenda Silva 2020. Around 200,304,173 cases have been registered for COVID-19 as of now and it's growing. Hence this factor is boosting the growth of testing laboratories and clinical diagnostics. As per World Health Organization (WHO), the occurrence of chronic diseases is expected to rise by 58% in 2020. Due to the huge occurrence, the demand for testing and diagnostic in the health care industry is likely to motivate market growth. As clinical diagnostics has proven a beneficial way of identifying chronic diseases and their infection rate in the body. As clinical diagnostics acts as an early warning to avoid harmful effects or proliferation of the diseases for example detection of cancer in early stages can be preventive and curable. Thus, the rising occurrence of clinical diseases is likely to create opportunities for the market players to enter the market and generate revenue. And this factor is likely to propel the overall market size in the forecast period.

Global Clinical Diagnostics Market Segment Analysis:

The Lipid Panel segment is anticipated to adhere to the growth of the Clinical Diagnostics Market. The lipid panel segment is dominating the clinical diagnostics market. The growth of the segment is attributed to rising obesity, cholesterol level, heart-related disease, and others. A lipid panel is a blood test that measures lipid, fats, where the body uses all these substances as an energy source. Moreover, fluctuation in total cholesterol, LDL-C (Low-Density Lipoprotein) and HDL (High-Density Lipoprotein) levels in patients can cause various complications in the body. In the COVID-19 pandemic patient suffering from Corona Virus (SARs-Cov-2) were observed and noted that patients with COVID-19 infection have decreased LDL-C/HDL-C and were more prone to high risk of disease infection and illness. Whereas, patients with high HDL-C levels were at lower risk, and patients with decreased HDL-C were at high risk and had the risk of developing diseases in them which boosted the demand for testing and clinical diagnostics. As per the American Heart Association Research Report in 2018, Cardiovascular disease was the major cause of death. Around 836,558 deaths were caused due to cardiovascular disease. And approximately, 2,300 Americans died each day due to Cardiovascular diseases with an average of 1 death in every 30 seconds. Hence this factor boosted the lipid panel testing which further boosted the growth of the market. The Instrument segment is supplementing the growth of the Clinical Diagnostics Market. The instrument is dominating the product segment of the clinical diagnostics market. As instruments are widely essential for the testing and diagnostics by the physicians. The role of diagnostic instruments is such as metabolic indicators like glucose, urea, and potassium, liver function test, heart disease, and heart attacks indicators, thyroid diseases markers, viral and microbial infection test HIV, etc. Immunological indicators and antibodies, various blood cell count and blood cell size, and various others. The global medical devices market was valued was USD 456.7 billion in 2019 and is anticipated to grow with a CAGR of 4.6%. in the forecast period. The diagnostic laboratories segment is Trending in the End-User Segment of Clinical Diagnostics Market. The diagnostic laboratories segment is dominating the end-user segment of the Clinical Diagnostic Market. And accounted for the revenue share of 54.0% in 2020. The growth of the market is amplifying due to rising test options and growing populations. Mounting technologies and development in clinical diagnosis are likely to supplement the growth of the market. Further, the surge in advanced treatment options with a low budget is predicted to lift the growth of the market in the forecast period. As chronic diseases and infectious diseases are growing in the elderly population, they are responsible to enhance the diagnostic laboratories market. In addition, the hospital's segment is largely occupied by clinical laboratories centers to offer a wide range of treatment and diseases identification tests to the admitted patient for their convenience. Further, mergers and tie-ups in hospitals and clinical diagnostic centers are likely to fuel the growth of the market in the forecast period. Point of care testing is likely to gain significant attention in the market and was valued at USD 27.66 billion in 2020. And is likely to grow with a CAGR of 3.45% during the forecast period. The growth of the segment is attributed to the growing demand for home healthcare, and this factor has propelled the growth of the POC testing segment. Global Clinical Diagnostics Market To know about the Research Methodology :- Request Free Sample Report

Global Clinical Diagnostics Market Regional Insights:

The Molecular Biology Enzymes, Reagents, and Kits market is regionally segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is leading in the Clinical Diagnostics market owing to the largest market share of 36.9% in 2020. North America is likely to grow by a CAGR of 9.3% in the forecast period. The growth of the region is endorsed by the mandate for advanced technology in the healthcare sector and high-end medical devices and instruments to offer patients advanced safety. Further, funding by healthcare organizations is likely to boost the growth of the market. For instance, in September 2020, the National Institute of Health, US, announced the funding of USD 129.3 million to the nine market players in the region. In which 3 major companies such as Maxim Biomedical Inc, MicroGEM International, and MatMaCorp were allotted for point-of-care test procedures for immediate results. And other 6 companies such as Aegis Sciences, Broad Institute, Ceres Nanoscience Inc, Illumina Inc, PathGroup, and Sonic Healthcare were allotted to gear up with a lab-based test. Global Clinical Diagnostics Market The objective of the report is to present a comprehensive analysis of the Global Clinical Diagnostics Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Clinical Diagnostics Market dynamics, structure by analyzing the market segments and project the Global Clinical Diagnostics Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Clinical Diagnostics Market make the report investor’s guide.

Global Clinical Diagnostics Market Scope: Inquire before buying

Global Clinical Diagnostics Market

Global Clinical Diagnostics Market, by Region

• North America o U.S. o Canada • Europe o Germany o The U.K. o France o Spain o Italy o Netherlands • Asia Pacific o Japan o China o India o South Korea o Australia o Singapore • Latin America o Brazil • The Middle East and Africa (MEA) o South Africa

Global Clinical Diagnostics Market Key Players

Bioscientia HealthcareCharles River LaboratoriesAbbott Laboratories • Diagnostic BioSystems • Labco • Sonic HealthcareSiemens Healthcare • Quest Diagnostics • ERBA Diagnostics Mexico S.A. • ARUP Laboratories • Healthscope • Bio-Reference Laboratories.

FAQs:

1. What is the Global Clinical Diagnostics market share in 2020? Ans: Approximately, 63,305 million USD. 2. What is the Global Clinical Diagnostics market growth? Ans: The Clinical Diagnostics market is anticipated to grow with a CAGR of 6.2% in the forecast period and is likely to reach 93,851.00 million by the end of 2027. 3. Which end-user is expected to dominate the Global Clinical Diagnostics market during the forecast period? Ans: The Diagnostic laboratories segment held the largest revenue share of over 54.00% in 2020 and will expand further at the second-fastest CAGR from 2021 to 2028 in the Clinical Diagnostics market. 4. Who are the key players in the Global Clinical Diagnostics market? Ans: Some key players operating in the Clinical Diagnostics market include Bioscientia Healthcare, Charles River Laboratories, Abbott Laboratories, Diagnostic BioSystems, Labco, Sonic Healthcare, Siemens Healthcare, Quest Diagnostics, ERBA Diagnostics Mexico S.A., ARUP Laboratories, Healthscope, Bio-Reference Laboratories. 5. What are the key driving factors for the growth of the Clinical Diagnostics market? Ans: Key factors that are driving the Clinical Diagnostics market growth are the rising burden of chronic diseases, demand for home healthcare testing is fueling the growth of the market.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Application 2.3.2. Primary Research 2.3.2.1. Data from Primary Application 2.3.2.2. Breakdown of Primary Application 3. Executive Summary: Clinical Diagnostics Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Clinical Diagnostics Market 3.4. Geographical Snapshot of the Clinical Diagnostics Market, By Manufacturer share 4. Clinical Diagnostics Market Overview, 2019-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porter Five Forces Analysis 4.1.6.1. The threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. The threat of Substitute Grades 4.1.6.5. The intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Clinical Diagnostics Market 5. Supply Side and Demand Side Indicators 6. Global Clinical Diagnostics Market Analysis and Forecast, 2019-2027 6.1. Clinical Diagnostics Market Size & Y-o-Y Growth Analysis. 7. Global Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 7.1. Market Size (Value) Estimates & Forecast By Product, 2019-2027 7.1.1. Lipid Panel 7.1.2. Liver Panel 7.1.3. Renal Panel 7.1.4. Complete Blood Count 7.1.5. Electrolyte Testing 7.1.6. Infectious Disease Testing 7.1.7. Other Tests. 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 7.2.1. Instrument 7.2.2. Reagent 7.2.3. Other 7.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 7.3.1. Hospital Laboratory 7.3.2. Diagnostic Laboratory 7.3.3. Point-of-care Testing 7.3.4. Other 8. Global Clinical Diagnostics Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 9.1. Market Size (Value) Estimates & Forecast By Product, 2019-2027 9.1.1. Lipid Panel 9.1.2. Liver Panel 9.1.3. Renal Panel 9.1.4. Complete Blood Count 9.1.5. Electrolyte Testing 9.1.6. Infectious Disease Testing 9.1.7. Other Tests. 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 9.2.1. Instrument 9.2.2. Reagent 9.2.3. Other 9.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 9.3.1. Hospital Laboratory 9.3.2. Diagnostic Laboratory 9.3.3. Point-of-care Testing 9.3.4. Other 10. North America Clinical Diagnostics Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 11.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 11.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 12. Canada Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 12.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 12.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 13. Mexico Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 13.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 13.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 14. Europe Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 14.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 14.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 15. Europe Clinical Diagnostics Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 16.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 16.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 17. France Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 17.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 17.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 18. Germany Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 18.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 18.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 19. Italy Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 19.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 19.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 20. Spain Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 20.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 20.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 21. Sweden Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 21.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 21.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 22. CIS Countries Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 22.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 22.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 23. Rest of Europe Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 23.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 23.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 24. Asia Pacific Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 24.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 24.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 25. Asia Pacific Clinical Diagnostics Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 26.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 26.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 27. India Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 27.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 27.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 28. Japan Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 28.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 28.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 29. South Korea Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 29.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 29.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 30. Australia Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 30.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 30.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 31. ASEAN Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 31.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 31.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 32. Rest of Asia Pacific Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 32.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 32.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 33. Middle East Africa Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 33.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 33.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 34. Middle East Africa Clinical Diagnostics Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 35.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 35.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 36. GCC Countries Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 36.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 36.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 37. Egypt Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 37.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 37.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 38. Nigeria Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 38.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 38.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 39. Rest of ME&A Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 39.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 39.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 40. South America Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 40.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 40.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 41. South America Clinical Diagnostics Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 42.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 42.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 43. Argentina Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 43.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 43.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 44. Rest of South America Clinical Diagnostics Market Analysis and Forecasts, 2019-2027 44.1. Market Size (Value) Estimates & Forecast By Product’s, 2019-2027 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2027 44.3. Market Size (Value) Estimates & Forecast By End-Use, 2019-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Clinical Diagnostics Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Fiber Grades, and R&D Investment 45.2.2. New Grade Launches and Grade Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment, and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures, and Strategic Alliances/ Sales Agreements 45.3. Company Profile: Key Players 45.3.1. Medtronic 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Grade Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. - Bioscientia Healthcare 45.3.3. Charles River Laboratories 45.3.4. Abbott Laboratories 45.3.5. Diagnostic BioSystems 45.3.6. Labco 45.3.7. Sonic Healthcare 45.3.8. Siemens Healthcare 45.3.9. Quest Diagnostics 45.3.10. ERBA Diagnostics Mexico S.A. 45.3.11. ARUP Laboratories 45.3.12. Healthscope 45.3.13. Bio-Reference Laboratories. 46.Primary Key Insights

About This Report

Report ID 116258
Category Healthcare
Published Date Aug 2021
Updated Date
Contact Us